Quantrx Biomedical Corp (QTXB) financial statements (2020 and earlier)

Company profile

Business Address P.O. BOX 4960
TUALATIN, OR 97062
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 000000
Cash and cash equivalents 000000
Receivables     00
Inventory, net of allowances, customer advances and progress billings      0
Inventory      0
Prepaid expense 00000 
Deposits current assets    0  
Prepaid expense and other current assets0
Other undisclosed current assets  0   0
Total current assets: 010000
Noncurrent Assets
Property, plant and equipment    000
Long-term investments and receivables 010000
Long-term investments 010000
Intangible assets, net (including goodwill)  (0)0000
Intangible assets, net (excluding goodwill)  (0)0000
Other undisclosed noncurrent assets  0    
Total noncurrent assets: 010000
TOTAL ASSETS: 110000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 000010
Accounts payable 000000
Accrued liabilities 000000
Debt 2211  
Due to related parties 0  0  
Other undisclosed current liabilities 001011
Total current liabilities: 222221
Noncurrent Liabilities
Long-term debt and lease obligation   0000
Long-term debt, excluding current maturities   0000
Total noncurrent liabilities:   0000
Total liabilities: 222221
Stockholders' equity
Stockholders' equity attributable to parent, including: (2)(1)(2)(1)(1)(1)
Preferred stock 000000
Common stock 111111
Common stock, value, subscriptions 00   
Additional paid in capital 494949494848
Accumulated deficit (51)(51)(51)(51)(51)(50)
Warrants and rights outstanding      2
Other undisclosed stockholders' equity attributable to parent     0(1)
Total stockholders' equity: (2)(1)(2)(1)(1)(1)
TOTAL LIABILITIES AND EQUITY: 110000

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 0  000
Revenue, net  000
Net investment income 0     
Cost of revenue (0)(2)(0)(0) (0)
Gross profit: (0)(2)(0)(0)0(0)
Operating expenses (0)1(0)(0)(1)(0)
Other undisclosed operating income (loss) (0)   1 
Operating loss: (0)(0)(0)(0)(0)(0)
Nonoperating income (expense) (1)1(0) 00
Investment income, nonoperating     00
Other nonoperating income (expense) (1)1(0)   
Interest and debt expense 0(0)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes: (1)1(0)(0)(0)(0)
Income from equity method investments     00
Other undisclosed income (loss) from continuing operations before income taxes (0)00(0)(0)(0)
Net income (loss) available to common stockholders, diluted: (1)1(0)(0)(1)(0)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss): (1)1(0)(0)(1)(0)
Comprehensive income (loss), net of tax, attributable to parent: (1)1(0)(0)(1)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: